跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,209 条关于
“Canon Marketing Japan”
全部
8,209
临床试验
2,879
药物
470
机构
197
资讯
4,663
去年
Fremanezumab Demonstrates Long-Term Efficacy in Migraine Prevention Across Multiple Real-World Studies
去年
Eisai and Sato Pharmaceutical Restructure Nailin Antifungal Marketing Partnership in Japan
10个月前
Canon Medical Receives FDA Clearance for Advanced Interventional Imaging Systems with AI-Enhanced Technology
去年
Eisai's Remitoro Clears Post-Marketing Surveillance Requirements for T-Cell Lymphoma Treatment in Japan
2个月前
Disruption of de novo fatty acid biosynthesis rewires cellular lipid metabolism toward mTOR signaling
3年前
4SC's Resminostat Advances Towards European Market Approval for CTCL Maintenance Therapy
去年
Japan Recommends Approval for Brukinsa and Balversa; Grants Sakigake Designation to Brogidirsen and Iclepertin
3年前
Janssen Seeks EMA Approval for Macitentan/Tadalafil Single-Tablet Combination in Pulmonary Arterial Hypertension
去年
Renalys Pharma Completes Enrollment in Phase III Trial of Sparsentan for IgA Nephropathy in Japan
去年
Lupkynis (Voclosporin) Approved in Japan for Lupus Nephritis Treatment
第 1 页,共 467 页
上一页
下一页